Literature DB >> 2651912

Further characterization and partial amino acid sequence of a cysteine proteinase from Trypanosoma cruzi.

J J Cazzulo1, R Couso, A Raimondi, C Wernstedt, U Hellman.   

Abstract

A cysteine proteinase from epimastigotes of Trypanosoma cruzi, Tul 2 stock, has been purified to homogeneity from cell-free extracts obtained by freezing and thawing, by a procedure involving ammonium sulfate fractionation, DEAE-Sephacel chromatography, and gel filtration on Sephadex G-200; when necessary, further purification was attained by fast protein liquid chromatography on Mono Q and Superose 6 columns. The purified enzyme was strongly inhibited by leupeptin, antipain and chymostatin (I50 values of 0.25, 0.75 and 1 microM, respectively), little inhibited by elastatinal, and unaffected by pepstatin A. The enzyme is a glycoprotein, as shown by binding to ConA-Sepharose and elution with alpha-methyl-D-mannopyranoside and alpha-methyl-D-glucopyranoside. Partial amino acid sequences were obtained from the N-terminal end (32 amino acids) of the carbamidomethylated enzyme, and from a tryptic peptide (14 amino acids) of the pyridylethylated enzyme. Both regions show considerable homology with papain and some cathepsins, such as cathepsin L, thus showing that the enzyme belongs to the cysteine proteinase family.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2651912     DOI: 10.1016/0166-6851(89)90039-x

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  16 in total

1.  The NADP+-linked glutamate dehydrogenase from Trypanosoma cruzi: sequence, genomic organization and expression.

Authors:  P Barderi; O Campetella; A C Frasch; J A Santomé; U Hellman; U Pettersson; J J Cazzulo
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

2.  Investigation of the substrate specificity of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, through the use of cystatin-derived substrates and inhibitors.

Authors:  C Serveau; G Lalmanach; M A Juliano; J Scharfstein; L Juliano; F Gauthier
Journal:  Biochem J       Date:  1996-02-01       Impact factor: 3.857

3.  Trypanosoma cruzi calreticulin is a lectin that binds monoglucosylated oligosaccharides but not protein moieties of glycoproteins.

Authors:  C Labriola; J J Cazzulo; A J Parodi
Journal:  Mol Biol Cell       Date:  1999-05       Impact factor: 4.138

4.  Alterations in the surface charge of heart muscle cells during interaction with Trypanosoma cruzi.

Authors:  M de N Soeiro; F Costa e Silva Filho; M de N Leal de Meirelles
Journal:  Cell Biophys       Date:  1995-02

5.  Review on Trypanosoma cruzi: Host Cell Interaction.

Authors:  Wanderley de Souza; Tecia Maria Ulisses de Carvalho; Emile Santos Barrias
Journal:  Int J Cell Biol       Date:  2010-07-29

6.  Differentiation of Trypanosoma cruzi I (TcI) and T. cruzi II (TcII) genotypes using genes encoding serine carboxypeptidases.

Authors:  Catarina Andréa Chaves de Araújo; Christoph Mayer; Peter Josef Waniek; Patricia Azambuja; Ana Maria Jansen
Journal:  Parasitol Res       Date:  2016-07-28       Impact factor: 2.289

7.  The major cysteine proteinase (cruzipain) from Trypanosoma cruzi is antigenic in human infections.

Authors:  J Martinez; O Campetella; A C Frasch; J J Cazzulo
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

8.  Further characterization of Trypanosoma cruzi GP57/51 as the major antigen expressed by differentiating epimastigotes.

Authors:  M C Bonaldo; J Scharfstein; A C Murta; S Goldenberg
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

Review 9.  Chagas' disease.

Authors:  H B Tanowitz; L V Kirchhoff; D Simon; S A Morris; L M Weiss; M Wittner
Journal:  Clin Microbiol Rev       Date:  1992-10       Impact factor: 26.132

10.  Trypanosomatid cysteine protease activity may be enhanced by a kininogen-like moiety from host serum.

Authors:  J D Lonsdale-Eccles; G W Mpimbaza; Z R Nkhungulu; J Olobo; L Smith; O M Tosomba; D J Grab
Journal:  Biochem J       Date:  1995-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.